Switching
28 results
Applied filters
Example medicines to prescribe by brand name in primary care
15 January 2026Prescribe certain medicines by brand to ensure supply of the same product. Examples are grouped by therapeutic area. The list of products is not exhaustive.
Switching between gabapentin and pregabalin for neuropathic pain
14 January 2026An overview of possible dose equivalences, switching methods and considerations to make before switching between immediate-release gabapentinoids.
Switching between pyridostigmine and neostigmine
23 December 2025Switching between pyridostigmine and neostigmine in myasthenia gravis requires care and application of a stepped process.
Using mesalazine tablets appropriately
19 December 2025An overview of differences between mesalazine tablet preparations and clinical considerations when switching between preparations.
Switching between aminophylline and theophylline in adults
4 July 2025Intravenous (IV) aminophylline is used in emergency respiratory conditions. We provide guidance on switching between oral theophylline and IV aminophylline.
Switching between morphine and other opioids in palliative care
1 April 2025Switching between oral morphine and other oral opioids requires care and thoughtful application of a stepped process.
An example oral opioid switch from morphine to oxycodone
1 April 2025An example scenario to support you when switching or advising on switching between morphine and other oral opioids in cancer and palliative care.
Estimating dose equivalence from oral morphine to other opioids
1 April 2025Use our tool to obtain approximate dose equivalences of oral morphine to other oral opioids and help you calculate an estimated equivalent daily dose.
Considerations when choosing an alternative antidepressant
17 September 2024Consider the risks associated with switching an antidepressant for depression, the patient's individual circumstances and when to seek specialist advice.
Monitoring a person during and after antidepressant switching
17 September 2024Review people at appropriate time points; advise on what to expect and report; and beware of the possibility of withdrawal symptoms and serotonin syndrome.